Report Highlights
-
BCC Research estimates that technological improvements and changes in health care cost control will cause the demand for medical device sensors to increase at a compound annual growth rate (CAGR) of 3.1% between 2009 and 2014, when it will approach $9 billion.
-
Semiconductor/MEMS sensors will experience a 5% compound annual growth rate (CAGR), from $5 billion in 2009 to an estimated $6.5 billion in 2014.
-
Passive medical device sensors were valued at $1.4 billion in 2009 and are expected to decline in value to $1.3 billion in 2014, a -2% compound annual growth rate (CAGR).
INTRODUCTION
- The medical and regulatory communities, who see sensors as providing a means of improving the safety and efficacy of medical devices
- Device manufacturers, who see devices as a means of making their products more useful and, equally important, more cost-effective
- Sensor manufacturers for whom products designed for medical devices are both a reliable profit center and a flagship product for showcasing their technological expertise
- Anesthesiology and respiratory therapy
- Cardiology
- Clinical chemistry
- Ear, nose, and throat practices
- Gastroenterology–urology
- General hospital
- General, orthopedic, and plastic surgery
- Hematology and pathology
- Neurology
- Obstetrics and gynecology
- Ophthalmology
- Orthopedics
- Radiology
- Passive sensors
- Active sensors
- Electromechanical sensors
- Semiconductor/MEMS sensors
- Analytical laboratory instrument manufacturers
- Electromedical and electrotherapeutic apparatus manufacturers
- Irradiation apparatus manufacturers
- Laboratory apparatus and furniture manufacturers
- Ophthalmic goods manufacturers
- Optical instrument and lens manufacturers
- Surgical and medical instrument manufacturers
- Surgical appliance and supplies manufacturersSCOPE of report (Continued)
- A U.S. dollar value for each of the four basic sensor technologies: passive, active, electromagnetic, and semiconductor/MEMS
- Historic sensor requirements for 2007 and 2008
- Forecast requirements for 2009 and 2014
- 2009 to 2014 compound annual growth rate (CAGR) calculation
- Examine BCC’s complete catalog of market research reports and place direct orders
- Subscribe to BCC’s industry newsletters
- Read announcements of recently published reports and newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers
Related Reports
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More